Real-world incidence of severe infections in multiple myeloma patients receiving bispecific antibodies: a meta-analysis
Abstract Bispecific antibodies (BiTEs) have transformed the therapeutic landscape of relapsed/refractory multiple myeloma (RRMM), offering deep and durable responses even in heavily pretreated patients. However, their use carries substantial infectious risk due to immunosuppression, particularly hyp...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer
2026-04-01
|
| シリーズ: | Annals of Hematology |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1007/s00277-026-07026-9 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|